Finance
Aytan Dahukey, partner and private equity team leader, and healthcare team member at Sheppard Mullin, says that growth areas in private equity are opportunistic and discusses some challenges ahead.
HIMSS24
Dr. Harm Scherpbier, HealthShare Exchange CMIO, describes how the company's platform connects practices, payers and ACOs, allowing them to share patients’ data in real time across facilities to coordinate care seamlessly.
Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.
The acquisition expands NeuroFlow's capabilities for behavioral health-focused measurement and engagement.
ChartSwap president Nate Kelly relays how patients and providers benefit from the company's electronic record request fulfillment, allowing them to review authorizations and receive faster payment for their time by automating custodian fees.
Also, Consultmed has released a new genAI feature on its referral management software.
HIMSS24
David Wolf, MedeAnalytics AVP, and Lynn Carroll, HSBlox COO, highlight value-based care models' crucial components, including contract modeling and performance measurement, and discuss change management for switching to these models.
The publicly traded company, which announced it was seeking strategic alternatives for its business last month, will go private thanks to the merger.
Cedar Gate Technologies EVP David Morris compares the new model, which allows for a gradual approach to risk for more conservative and less experienced ACOs, and ACO REACH, which requires a greater tolerance for risk, but has more rewards.